Evidence mapPaperPMID 41577710Full record

ArticleNature communications2026

Using the linear references from the pangenome to discover missing autism variants.

Yang Sui, Jiadong Lin, Michelle D Noyes, Youngjun Kwon, Isaac Wong, Nidhi Koundinya, William T Harvey, Mei Wu, Kendra Hoekzema, Katherine M Munson and 19 more

Abstract read
In one paragraph

Article in Nature communications, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

29 authors.

Yang SuiDepartment of Genome Sciences, University of Washington School of Medicine, Seattle, WA, USA.ORCID http://orcid.org/0000-0001-7285-8733
Jiadong LinDepartment of Genome Sciences, University of Washington School of Medicine, Seattle, WA, USA.
Michelle D NoyesDepartment of Genome Sciences, University of Washington School of Medicine, Seattle, WA, USA.
Youngjun KwonDepartment of Genome Sciences, University of Washington School of Medicine, Seattle, WA, USA.ORCID http://orcid.org/0000-0002-5024-2134
Isaac WongDepartment of Genome Sciences, University of Washington School of Medicine, Seattle, WA, USA.ORCID http://orcid.org/0000-0003-4877-5748
Nidhi KoundinyaDepartment of Genome Sciences, University of Washington School of Medicine, Seattle, WA, USA.ORCID http://orcid.org/0009-0008-7155-1287
William T HarveyDepartment of Genome Sciences, University of Washington School of Medicine, Seattle, WA, USA.ORCID http://orcid.org/0000-0003-0646-7528
Mei WuDepartment of Genome Sciences, University of Washington School of Medicine, Seattle, WA, USA.
Kendra HoekzemaDepartment of Genome Sciences, University of Washington School of Medicine, Seattle, WA, USA.
Katherine M MunsonDepartment of Genome Sciences, University of Washington School of Medicine, Seattle, WA, USA.ORCID http://orcid.org/0000-0001-8413-6498
Gage H GarciaDepartment of Genome Sciences, University of Washington School of Medicine, Seattle, WA, USA.ORCID http://orcid.org/0009-0005-2383-722X
Jordan KnuthDepartment of Genome Sciences, University of Washington School of Medicine, Seattle, WA, USA.ORCID http://orcid.org/0009-0007-0176-7093
Julie WertzDepartment of Genome Sciences, University of Washington School of Medicine, Seattle, WA, USA.ORCID http://orcid.org/0009-0000-3747-3221
Tianyun WangDepartment of Medical Genetics, Center for Medical Genetics, School of Basic Medical Sciences, Peking University Health Science Center, Beijing, China.ORCID http://orcid.org/0000-0002-5179-087X
Kelsey HennickDepartment of Neurological Surgery, University of California, San Francisco, CA, USA.ORCID http://orcid.org/0000-0002-6127-2400
Druha KarunakaranCenter for Human Genetics and Genomics, New York University Grossman School of Medicine, New York, NY, USA.
Rafael A Polo PrietoDepartment of Human and Molecular Genetics, Baylor College of Medicine, Houston, TX, USA.ORCID http://orcid.org/0000-0002-8150-0757
Rebecca Meyer-SchumanDepartment of Human and Molecular Genetics, Baylor College of Medicine, Houston, TX, USA.
Fisher CherryDepartment of Human and Molecular Genetics, Baylor College of Medicine, Houston, TX, USA.ORCID http://orcid.org/0009-0001-7646-8422
Davut PehlivanDepartment of Human and Molecular Genetics, Baylor College of Medicine, Houston, TX, USA.
Bernhard SuterTexas Children's Hospital, Houston, TX, USA.
Jonas A GustafsonDivision of Genetic Medicine, Department of Pediatrics, University of Washington, Seattle, WA, USA.ORCID http://orcid.org/0000-0002-5748-905X
Danny E MillerDivision of Genetic Medicine, Department of Pediatrics, University of Washington, Seattle, WA, USA.ORCID http://orcid.org/0000-0001-6096-8601
Human Pangenome Reference Consortium (HPRC)
Hanna Berk-RauchCenter for Human Genetics and Genomics, New York University Grossman School of Medicine, New York, NY, USA.
Tomasz J NowakowskiDepartment of Neurological Surgery, University of California, San Francisco, CA, USA.ORCID http://orcid.org/0000-0003-2345-4964
Aravinda ChakravartiCenter for Human Genetics and Genomics, New York University Grossman School of Medicine, New York, NY, USA.ORCID http://orcid.org/0000-0002-4264-2285
Huda Y ZoghbiDepartment of Human and Molecular Genetics, Baylor College of Medicine, Houston, TX, USA.ORCID http://orcid.org/0000-0002-0700-3349
Evan E EichlerDepartment of Genome Sciences, University of Washington School of Medicine, Seattle, WA, USA. ee3@uw.edu.ORCID http://orcid.org/0000-0002-8246-4014

Funding

Rare Mutations and Autism Spectrum DisordersR01MH101221 · NIMH · UNIVERSITY OF WASHINGTON · 2022 to 2025
$2.9M
Center for Human Genome Reference DiversityUM1HG010971 · UNIVERSITY OF CALIFORNIA SANTA CRUZ · 2025 to 2025
$2.8M
Long-read DNA and RNA sequencing to identify disease-causing genetic variation and streamline testingDP5OD033357 · UNIVERSITY OF WASHINGTON · 2025 to 2025
$778k
MOLECULAR PATHOGENESIS STUDIES OF RETT SYNDROMER01NS057819 · BAYLOR COLLEGE OF MEDICINE · 2025 to 2025
$401k
Defining critical MECP2 cis-regulatory elements towards identifying genetic candidates for male-biased autismF32HD116501 · BAYLOR COLLEGE OF MEDICINE · 2025 to 2025
$78k
Howard Hughes Medical Institute (HHMI) NANational Natural Science Foundation of China (National Science Foundation of China) 82201314National Natural Science Foundation of China (National Science Foundation of China) 82471194NHGRI NIH HHS UM1 HG010971NICHD NIH HHS F32 HD116501NIH HHS DP5 OD033357NIMH NIH HHS R01 MH101221Simons Foundation SFARI #810018U.S. Department of Health & Human Services | National Institutes of Health (NIH) 1F32HD116501-01U.S. Department of Health & Human Services | National Institutes of Health (NIH) DP5OD033357U.S. Department of Health & Human Services | NIH | National Human Genome Research Institute (NHGRI) R01NS057819U.S. Department of Health & Human Services | NIH | National Institute of Mental Health (NIMH) R01MH101221
6 · The paper itself

Abstract

To better understand large-effect pathogenic variation associated with autism, we generated long-read sequencing (LRS) data to construct phased and near-complete genome assemblies (average contig N50 = 43 Mbp, QV = 56) for 189 individuals from 51 families with unsolved cases. We applied read- and assembly-based strategies to facilitate comprehensive characterization of de novo mutations, structural variants (SVs), and DNA methylation. Using LRS pangenome controls, we efficiently filtered >97% of common SVs exclusive to 87 offspring. We find no evidence of increased autosomal SV burden for probands when compared to unaffected siblings yet observe a suggestive trend toward an increased SV burden on the X chromosome among affected females. We establish a workflow to prioritize potential pathogenic variants by integrating autism risk genes and putative noncoding regulatory elements defined from ATAC-seq and CUT&Tag data from the developing cortex. In total, we identified three pathogenic variants in TBL1XR1, MECP2, and SYNGAP1, as well as nine candidate de novo and biallelic inherited homozygous SVs, most of which were missed by short-read sequencing. Our work highlights the potential of phased genomes to discover complex more pathogenic mutations and the power of the pangenome to restrict the focus on an increasingly smaller number of SVs for clinical evaluation.

Indexed as

Autistic DisorderGenome, HumanChromosomes, Human, XDNA MethylationFemaleGenetic Predisposition to DiseaseGenetic VariationHumansMethyl-CpG-Binding Protein 2Mutationras GTPase-Activating ProteinsRepressor ProteinsMECP2 protein, humanMethyl-CpG-Binding Protein 2ras GTPase-Activating ProteinsRepressor Proteins

Identifiers

PMID41577710
PMCPMC12909954

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.